New York
Bronx; Biomedical Research Alliance of New York
EKOS® Ultrasound Accelerated Thrombolysis with Lytic Bolus for Resolution of Arterial and Venous Occlusions [BRAVO study]
New York; New York Presbyterian Hospital-Weill Cornell University
A Phase II/III Pivotal trial evaluating the safety and pharmacokinetic properties of a plasma derived antithrombin III concentrate with administration for surgery, pregnancy and serious thromboembolic or thrombotic events
Ohio
Cleveland; Cleveland Clinic Foundation
A Phase II/III Pivotal trial evaluating the safety and pharmacokinetic properties of a plasma derived antithrombin III concentrate with administration for surgery, pregnancy and serious thromboembolic or thrombotic events
Texas
Houston; University of Texas Health Science Center
A Phase II/III Pivotal trial evaluating the safety and pharmacokinetic properties of a plasma derived antithrombin III concentrate with administration for surgery, pregnancy and serious thromboembolic or thrombotic events
Virginia
Charlottesville; UVA Health System
A Phase II/III Pivotal trial evaluating the safety and pharmacokinetic properties of a plasma derived antithrombin III concentrate with administration for surgery, pregnancy and serious thromboembolic or thrombotic events
Washington, DC
Washington; Georgetown Univ. Med. Center
A Phase II/III Pivotal trial evaluating the safety and pharmacokinetic properties of a plasma derived antithrombin III concentrate with administration for surgery, pregnancy and serious thromboembolic or thrombotic events
